The U.S. Food and Drug Administration (FDA) has approved prademagene zamikeracel (Zevaskyn) for the treatment of blistering ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Patients with severe dystrophic epidermolysis bullosa, or EB, have skin so fragile, the slightest touch can lead to ...

The FDA has approved Zevaskyn (prademagene zamikeracel) for the treatment of recessive dystrophic epidermolysis bullosa, a rare genetic skin disorder.

With FDA approval, Zevaskyn is set to be a game-changer in the treatment of recessive dystrophic epidermolysis ...

Patients with the debilitating dermatologic condition are born with COL7A1 mutations in both gene copies, affecting the ability to produce functional type VII collagen and resulting in extremely ...

In a phase 3 trial, 81% of wounds treated with autologous cell sheet-based gene therapy showed ≥ 50% healing at 6 months, ...

Prademagene zamikeracel (Zevaskyn) is the first and only cell-based gene therapy for wound treatment in patients with ...

Actor Colin Farrell has opened up about the difficult decision to move his son James, who has Angelman syndrome, into a ...

To create awareness on rare skin conditions, the Rare Skin Conditions Society (Singapore) and the Dystrophic Epidermolysis Bullosa Research Association, Singapore, will be launching a book ...

Hannah announced on April 8 that Elliana had died less than one year after she was born with a rare skin condition called junctional epidermolysis bullosa (EB), which causes painful blistering.

He has been supporting Isla Grist, 16-year-old girl living with epidermolysis bullosa (EB) - a rare genetic skin condition often referred to as "butterfly skin". Explaining the illness ...